Robert Gareth Gish MD, FAASLD, AGAF, FAST

Dr. Robert Gish was, as the first step in his medical career, a student in Pharmacy School at the University of Kansas, and then obtained his medical degree from the University of Kansas Medical School in Kansas City, Kansas. He then completed a 3-year internal medicine residency at the University of California, San Diego, and a 4-year gastroenterology and hepatology fellowship at the University of California, Los Angeles, which included liver transplant medicine and an NIH grant in liver toxicity.

Dr. Gish is currently a fellow of the American Association for the Study of Liver Disease, the AGA, the American Society of Transplantation, and the American College of Physicians.

He has served on the editorial boards and is a reviewer of over 50 liver-related journals. He co-authored a public health policy for liver health in Vietnam, focusing on HBV, and is also assisting with the development of viral hepatitis health care policies in Uzbekistan, Georgia, Armenia, and the Philippines, among many others, in his role as the Medical Director of the Hepatitis B Foundation. He was a major early contributor to deciphering methods for the detection of hepatitis B and C viruses and characterizing their epidemiology and clinical presentation in humans. He has published more than 700 original articles, abstracts, and book chapters.

Robert G. Gish, MD, is currently the Medical Director of the Hepatitis B Foundation in Doylestown, Pennsylvania. He is an Adjunct Professor of Medicine at the University of Nevada School of Medicine in Las Vegas. He serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, a Clinical Professor of Medicine at Loma Linda University. Dr. Gish is currently seeing patients, both in-person and via telemedicine, at various clinics in San Diego, Folsom (El Dorado Hills), Santa Rosa, and Valley Springs. He is a staff physician at La Maestra, a federally qualified health center in San Diego. Dr. Gish also serves as a Board Member of the Viet Nam Viral Hepatitis Alliance (VVHA).